Growth factor regulation of remyleination: Behind the growing interest in endogenous cell repair of the CNS

Future Neurology

Volumn 2, Issue 6, 2007, Pages 689-697

  Armstrong, Regina C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cuprizone; Demyelinating disease; FGF; Multiple sclerosis; Myelin; Oligodendrocyte; PDGF; Progenitors; Remyelination

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; DEMYELINATION; GENE OVEREXPRESSION; HORMONAL REGULATION; HUMAN; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE CELL STIMULATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TRANSGENE;

EID: 36148953265     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/14796708.2.6.689     Document Type: Review

References (59)

1. Raff MC, Miller RH, Noble M: A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303(5916), 390-396 (1983).
2. Lassmann H: Experimental models of multiple sclerosis. Rev. Neurol. 163(6-7), 651-655 (2007).
3. Cannella B, Pitt D, Capello E, Raine CS: Insulin-like growth factor-1 falls to enhance central nervous system myelin repair during autoimmune demyelination. Am. J. Pathol. 157(3), 933-943 (2000).
4. Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ: Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 53(7), 696-703 (2006).
5. Decker L, Picard-Riera N, Lachapelle F, Baron-Van Evercooren A: Growth factor treatment promotes mobilization of young but not aged adult subventricular zone precursors in response to demyelination. J. Neurosci. Res. 69(6), 763-771 (2002).
6. Penderis J, Shields SA, Franklin RJ: Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 126(Pt 6), 1382-1391 (2003).
7. Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ: Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol. Cell. Neurosci. 25(2), 252-262 (2004).
8. Blakemore WF, Gilson JM, Crang AJ: The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp. Neurol. 184(2), 955-963 (2003).
9. Williams A, Platon G, Lubetzki C: Astrocytes - friends or foes in multiple sclerosis? Glia 55(13), 1300-1312 (2007).
10. Mason JL, Toews A, Hostettler JD et al.: Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am. J. Pathology 164(5), 1673-1682 (2004).
11. Armstrong RC, Le TQ, Flint NC, Vana AC, Zhou YX: Endogenous cell repair of chronic demyelination. J. Neuropath. Exp. Neurol. 65(3), 245-256 (2006).
12. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES: Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33(2), 137-151 (1993).
13. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK: Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 20(15), 5703-5708 (2000).
14. Talbott JF, Cao Q, Bertram J et al.: CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo. Exp. Neurol. 204(1), 485-489 (2007).
15. Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K, Matsushima GK: Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/ remyelination. J. Neurosci. Res. 61(3), 251-262 (2000).
16. Reynolds R, Dawson M, Papadopoulos D et al.: The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J. Neurocytol. 31 (6-7), 523-536 (2002).
17. Kotter MR, Li WW, Zhao C, Franklin RJ: Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 26(1), 328-332 (2006).
18. Bruck W, Stadelmann C: Inflammation and degeneration in multiple sclerosis. Neurol. Sci. 24(Suppl. 5), S265-S267 (2003).
19. Patriklos P, Stadelmann C, Kutzelnigg A et al.: Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129(Pt 12), 3165-3172 (2006).
20. Patani R, Balaratnam M, Vora A, Reynolds R: Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropath. Appl. Neurobiol. 33(3), 277-287 (2007).
21. Bieber AJ, Ure DR, Rodriguez M: Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis. J. Neuropath. Exp. Neurol. 64(1), 46-57 (2005).
22. Redwine JM, Armstrong RC: In vivo proliferation of oligodendrocyte progenitors expressing PDGFαR during early remyelination. J. Neurobiol. 37(3), 413-428 (1998).
23. Wolswijk G, Noble M: Cooperation between PDGF and FGF converts slowly dividing O-2A adult progenitor cells to rapidly dividing cells with characteristics of O-2A perinatal progenitor cells. J. Cell Biol. 118(4), 889-900 (1992).
24. Frost EE, Nielsen JA, Le TQ, Armstrong RC: PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J. Neurobiol. 54(3), 457-472 (2003).
25. Wilson HC, Scolding NJ, Raine CS: Co-expression of PDGF α receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J. Neuroimmunol. 176(1-2), 162-173 (2006).
26. Hinks GL, Franklin RJ: Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-β1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol. Cell Neurosci. 14(2), 153-168 (1999).
27. Maeda Y, Solanky M, Menonna J, Chapin J, Li W, Dowling P: Platelet-derived growth factor-α receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann. Neurol. 49(6), 776-785 (2001).
28. Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC: PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol. Dis. 19(1-2), 171-182 (2005).
29. Vana A, Flint N, Harwood N, Le T, Fruttiger M, Armstrong R: Platelet-derived growth factor (PDGF) promotes repair of chronically demyelinated white matter. J. Neuropath. Exp. Neurol. (2007) (In press).
30. Keirstead HS, Levine JM, Blakemore WF: Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22(2), 161-170 (1998).
31. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP: TNF α promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neurosci. 4(11), 1116-1122 (2001).
32. van Oosten BW, Barkhof F, Truyen L. et al.: Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47(6), 1531-1534 (1996).
33. Hohlfeld R, Kerschensteiner M, Meinl E: Dual role of inflammation in CNS disease. Neurology 68(22 Suppl. 3), S58-S63; discussion S91-S56 (2007).
34. Zawadzka M, Franklin RJ: Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology. Curr. Opin Neurol. 20(3), 294-298 (2007).
35. Foote AK, Blakemore WF: Repopulation of oligodendrocyte progenitor cell-depleted tissue in a model of chronic demyelination. Neuropath. Appl. Neurobiol. 31(4), 374-383 (2005).
36. Messersmith DJ, Murtie JC, Le TQ, Frost EE, Armstrong RC: Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J. Neurosci. Res. 62(2), 241-256 (2000).
37. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC: Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J. Neurosci. 22(19), 8574-8585 (2002).
38. Ruffini F, Furlan R, Poliani PL et al.: Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther. 8(16), 1207-1213 (2001).
39. Matsushima GK, Morell P: The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11(1), 107-116 (2001).
40. Gensert JM, Goldman JE: Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19(1), 197-203 (1997).
41. Franklin RJ, Gilson JM, Blakemore WF: Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J. Neurosci. Res. 50(2), 337-344 (1997).
42. Aguirre A, Dupree JL, Mangin JM, Gallo V. A functional role for EGFR signaling in myelination and remyelination. Nat. Neurosci. 10(8), 990-1002 (2007).
43. Chang A, Tourtellotte WW, Rudick R, Trapp BD: Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346(3), 165-173 (2002).
44. Nait-Oumesmar B, Picard-Riera N, Kerninon C et al.: Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc. Natl Acad. Sci. USA 104(11), 4694-4699 (2007).
45. Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A. EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron 36(6), 1021-1034 (2002).
46. Martens DJ, Seaberg RM, van der Kooy D: In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord. Eur. J. Neurosci. 16(6), 1045-1057 (2002).
47. Wolswijk G: Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18(2), 601-609 (1998).
48. Wolswijk G: Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123 (Pt 1). 105-115 (2000).
49. Wolswijk G: Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125(Pt 2). 338-349 (2002).
50. Holley JE, Gveric D, Newcombe J, Cuzner ML. Gutowski NJ: Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol. Appl. Neurobiol. 29(5), 434-444 (2003).
51. Viehover A, Miller RH, Park, SK, Fischbach G, Vartanian T: Neuregulin: an oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev. Neurosci. 23(4-5), 377-386 (2001).
52. Mason JL, Suzuki K, Chaplin DD, Matsushima GK: Interleukin-1β promotes repair of the CNS. J. Neurosci. 21(18), 7046-7052 (2001).
53. Chesik D, Wilczak N, De Keyser J: The insulin-like growth factor system in multiple sclerosis. Int. Rev. Neurobiol. 79, 203-226 (2007).
54. Zhang Y, Taveggia C, Melendez-Vasquez C et al.: Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J. Neurosci. 26(47), 12174-12185 (2006).
55. Kumar S. Biancotti JC, Yamaguchi M et al.: Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model. Neurochem. Res. 32, 783-797 (2007).
56. Zujovic V, Bachelin C, Baron-Van Evercooren A: Remyelination of the central nervous system: a valuable contribution from the periphery. Neuroscientist 13(4), 383-391 (2007).
57. Sarchielli P, Greco L, Stipa A, Floridi A, Gallai V: Brain-derived neurotrophic factor in patients with multiple sclerosis. J. Neuroimmunol. 132(1-2), 180-188 (2002).
58. Dai X, Lercher LD, Clinton PM et al.: The trophic role of oligodendrocytes in the basal forebrain. J. Neurosci. 23(13), 5846-5853 (2003).
59. Du Y, Fischer TZ, Clinton-Luke P, Lercher LD, Dreyfus CF: Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes. Mol. Cell. Neurosci. 31(2), 366-375 (2006).